Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 367
interventional 261
Observational 100
Registry 6

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 139
Drug|placebo 39
Biological 25
Other 14
Device 9
Procedure 7
Behavioral 4
Dietary Supplement 3
Dietary Supplement|placebo 3
Other|Procedure 3
Biological|placebo 2
Device|Other 2
Device|Procedure 2
Behavioral|Drug 1
Behavioral|Other 1
Behavioral|Procedure 1
Biological|Drug 1
Biological|placebo|Procedure 1
Combination Product|Other 1
Device|Drug 1
Diagnostic Test 1
Drug|Other 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 82
NA 33
France 18
Australia 13
Germany 6
Netherlands 6
Spain 5
United Kingdom 5
Belgium 4
Canada 4
Singapore 4
China 3
Italy 3
Sweden 3
Brazil 2
India 2
Israel 2
Kenya 2
Korea, Republic of 2
South Africa 2
United States|Canada 2
Austria 1
Bangladesh 1
Belgium|Canada 1
Bulgaria|United States|Germany|India 1
Chile 1
Chile|Peru|Argentina 1
Colombia 1
Denmark 1
Egypt 1
Fiji 1
Finland 1
Gambia 1
Georgia|India|Kazakhstan|Lesotho|Pakistan|Peru|South Africa 1
Germany|Canada|Costa Rica|France|India|Mexico|Netherlands|Peru|Poland|South Africa 1
Germany|Poland 1
Germany|Switzerland 1
Ghana 1
Greece|Israel|Italy 1
Japan 1
Jordan 1
Kuwait 1
Malawi|South Africa 1
Mali 1
Nepal 1
Poland 1
Qatar 1
Saudi Arabia 1
Spain|United Kingdom 1
Taiwan 1
Thailand 1
Turkey 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Colombia|Croatia|Denmark|Estonia|Finland|France|Germany|Greece|Hungary|India|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|Panama|Peru|Poland|Portugal|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Brazil|Germany|Mexico|New Zealand|Poland|Russian Federation|South Africa|Spain 1
United States|Argentina|Austria|Brazil|Chile|Germany|Latvia|Mexico|Poland|Russian Federation|Ukraine|United Kingdom 1
United States|Argentina|Belarus|Bulgaria|Chile|Colombia|Georgia|Greece|Guatemala|Latvia|Lithuania|Mexico|Panama|Poland|Romania|Russian Federation|South Africa|Spain|Ukraine 1
United States|Argentina|Brazil|Bulgaria|Chile|Estonia|Georgia|Hungary|Korea, Republic of|Latvia|Mexico|Moldova, Republic of|Peru|Romania|Slovakia|Taiwan 1
United States|Argentina|Brazil|Canada|Czechia|Germany|Hungary|Latvia|Peru|Slovakia|Ukraine 1
United States|Argentina|Brazil|Chile|Germany|Mexico|Peru|Poland|Romania|Russian Federation|Ukraine 1
United States|Argentina|Brazil|India|South Africa 1
United States|Argentina|Chile|Costa Rica|Germany|Mexico|Netherlands|South Africa|Taiwan 1
United States|Belarus|Belgium|Brazil|Estonia|France|Georgia|India|Israel|Latvia|Mexico|Russian Federation|Serbia|South Africa|Turkey|Ukraine 1
United States|Belgium|Germany|Latvia|Lithuania|Poland 1
United States|Belgium|Mexico|South Africa|Taiwan|Ukraine 1
United States|Belgium|United Kingdom 1
United States|Brazil|Canada|Italy|Mexico|Spain 1
United States|Bulgaria 1
United States|Bulgaria|Colombia|Greece|Norway|Poland|Ukraine|United Kingdom 1
United States|Bulgaria|Croatia|Greece|Hungary|Israel|Latvia|Peru|Poland|Romania|South Africa|Spain|Turkey|Ukraine 1
United States|Canada|Puerto Rico 1
United States|China|Philippines|Taiwan 1
United States|Colombia|France|Israel|Mexico|Philippines|Poland|Russian Federation|South Africa|Spain|Turkey 1
United States|Croatia|Israel|Latvia|Russian Federation|Spain|Ukraine 1
United States|Estonia 1
United States|Estonia|Hungary|India|Italy|Slovakia|Taiwan 1
United States|India 1
United States|Puerto Rico 1
United States|Slovakia|Spain|Taiwan 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 163
2 15
3 12
4 7
5 4
6 3
7 5
8 1
9 3
10 1
11 3
12 3
13 3
14 2
15 2
19 1
21 2
22 1
23 1
25 1
30 1
31 1
33 1
34 1
36 1
38 2
45 1
46 1
50 2
51 1
52 1
53 1
54 2
56 1
59 1
69 1
75 1
78 1
84 2
92 1
94 1
100 1
118 1
211 1

Phase

Phase Study_Count
Phase 1 79
Phase 3 53
N/A 50
Phase 4 41
Phase 2 30
Phase 1/Phase 2 5
Phase 2/Phase 3 3

Number of Arms

Number_of_Arms Count_of_Studies
1 40
2 115
3 25
4 16
5 6
6 7
7 3
8 3
9 1
10 1
11 1
12 1
NA 42

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 4.00 3.00000 8.0 22.00 140.0000 13.0000 0.000
1st Qu. 42.50 24.00000 73.0 65.00 225.5000 212.0000 60.000
Median 133.00 40.00000 74.0 120.00 311.0000 497.0000 132.000
Mean 1813.46 50.26027 112.6 189.20 383.6667 586.2642 1146.268
3rd Qu. 682.50 52.00000 122.0 213.75 505.5000 739.0000 406.000
Max. 30000.00 449.00000 286.0 756.00 700.0000 2808.0000 30024.000

Trial Group Type

group_type Group_Count
Experimental 364
Active Comparator 115
Placebo Comparator 51
NA 42
Other 23
No Intervention 15

Intervention Model

intervention_model Study_Count
Parallel Assignment 159
Single Group Assignment 64
Crossover Assignment 18
NA 11
Sequential Assignment 7
Factorial Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 149
Prevention 43
Basic Science 24
Other 11
Diagnostic 10
Health Services Research 8
Supportive Care 8
NA 7
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 25
France 14
NA 12
China 4
Netherlands 4
Germany 3
Israel 3
Korea, Republic of 3
Sweden 3
Switzerland 3
Canada 2
Hungary 2
Thailand 2
United Kingdom 2
Argentina 1
Australia 1
Austria 1
Austria|Germany 1
Belarus 1
Belgium 1
Burkina Faso 1
Denmark 1
Germany|Italy|United Kingdom 1
Italy 1
Malawi 1
Norway 1
Singapore 1
Spain 1
Taiwan 1
United States|Argentina|Brazil|Chile|Costa Rica|Israel|Mexico|Panama 1
United States|Australia|China|Colombia 1
United States|Germany|Italy 1

Sites per Study

Site_count Study_Count
1 76
2 7
3 4
4 3
6 1
7 1
8 1
10 1
19 1
21 1
22 1
25 1
63 1
123 1

Enrollment Metrics

Measure Observational
Min 1.00
1st Qu 88.25
Median 200.00
Mean 680.03
3rd Qu 500.50
Max 15000.00

Observation Model

observational_model Study_Count
Cohort 60
Case-Only 14
Other 8
NA 6
Case Control 5
Case-Control 3
Case Control, Natural History 2
Ecologic or Community 2

Time Perspective

time_perspective Study_Count
Prospective 74
Retrospective 19
Cross-Sectional 3
Longitudinal, Prospective 2
Other 2

Registries

Studies by Country

Country Study_Count
Belgium 1
Colombia|Germany|India|Turkey 1
France 1
Italy 1
NA 1
Norway 1

Sites per Study

Site_count Study_Count
1 2
2 1
11 1
15 1
54 1

Enrollment Metrics

Measure Registries
Min 150.0000
1st Qu 188.5000
Median 307.0000
Mean 709.3333
3rd Qu 507.2500
Max 2769.0000

Registry Model

observational_model Study_Count
Cohort 3
Case-Control 1
Case-Only 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 5
Other 1

Follow-up

target_duration Study_Count
30 Days 2
6 Months 2
2 Weeks 1
4 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04187144 Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI) https://ClinicalTrials.gov/show/NCT04187144 Recruiting GlaxoSmithKline 2021-12-20
NCT03408392 Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions https://ClinicalTrials.gov/show/NCT03408392 Completed GlaxoSmithKline 2018-03-13
NCT03369951 Minocycline Pharmacokinetics (ACUMIN) https://ClinicalTrials.gov/show/NCT03369951 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2019-07-20
NCT03361163 Controlled Human Infection for Vaccination Against Streptococcus Pyogenes https://ClinicalTrials.gov/show/NCT03361163 Completed Murdoch Childrens Research Institute 2019-09-28
NCT03299894 Impact of qSOFA Calculation on the Timing of Antimicrobial Therapy in the Emergency Department https://ClinicalTrials.gov/show/NCT03299894 Completed Centre Hospitalier Régional d’Orléans 2018-06-10
NCT03244917 Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer’s Disease and Other Dementias https://ClinicalTrials.gov/show/NCT03244917 Recruiting Hebrew Rehabilitation Center, Boston 2020-08-31
NCT03234738 A Phase 1 Safety and PK Study of IV TP-271 https://ClinicalTrials.gov/show/NCT03234738 Active, not recruiting Tetraphase Pharmaceuticals, Inc. 2018-10-31
NCT03233438 Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) https://ClinicalTrials.gov/show/NCT03233438 Completed Allergan 2018-10-30
NCT03230916 A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020) https://ClinicalTrials.gov/show/NCT03230916 Recruiting Merck Sharp & Dohme Corp. 2020-08-13
NCT03182504 A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants https://ClinicalTrials.gov/show/NCT03182504 Completed Hoffmann-La Roche 2017-08-10
NCT03163628 biomArkers to differeNtiate bacTerial From vIral iNfEctions https://ClinicalTrials.gov/show/NCT03163628 Completed Hospices Civils de Lyon 2019-06-12
NCT03150082 Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT03150082 Completed GlaxoSmithKline 2017-08-28
NCT03133312 Chlorhexidine Gluconate Versus Povidone-Iodine as Vaginal Preparation Antiseptics Prior to Cesarean Delivery https://ClinicalTrials.gov/show/NCT03133312 Completed Metro Health, Michigan 2017-12-30
NCT03124199 Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection https://ClinicalTrials.gov/show/NCT03124199 Completed Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 2015-03-31
NCT03079609 The Search for Viral and Bacterial Etiology of Varicocele https://ClinicalTrials.gov/show/NCT03079609 Active, not recruiting Medical University of Warsaw 2019-12-31
NCT03009734 Evaluation of ATx201 as a Topical Antibiotic Agent https://ClinicalTrials.gov/show/NCT03009734 Completed UNION therapeutics 2018-03-31
NCT02992951 DACC in the REduction of Surgical Site INfection https://ClinicalTrials.gov/show/NCT02992951 Completed Hull University Teaching Hospitals NHS Trust 2018-08-01
NCT02988349 Ecological Effect of Arginine Dentifrice on Oral Microbiota https://ClinicalTrials.gov/show/NCT02988349 Completed Sichuan University 2014-07-31
NCT02955459 VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT02955459 Completed VenatoRx Pharmaceuticals, Inc. 2017-06-30
NCT02914132 Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis https://ClinicalTrials.gov/show/NCT02914132 Completed ExThera Medical Corporation 2018-06-07
NCT02882568 Analysis of Immune Response In Bacterial Infection of Obese Subject https://ClinicalTrials.gov/show/NCT02882568 Completed Versailles Hospital 2016-02-29
NCT02877927 Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI https://ClinicalTrials.gov/show/NCT02877927 Completed Paratek Pharmaceuticals Inc 2017-05-26
NCT02858700 Value for Cord Blood Procalcitonin to Diagnose Early Neonatal Bacterial Infection https://ClinicalTrials.gov/show/NCT02858700 Completed University Hospital, Montpellier 2015-12-31
NCT02853435 To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects. https://ClinicalTrials.gov/show/NCT02853435 Completed GlaxoSmithKline 2017-10-17
NCT02814916 Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA https://ClinicalTrials.gov/show/NCT02814916 Recruiting Allergan 2021-12-31
NCT02754765 Evaluating Newly Approved Drugs for Multidrug-resistant TB https://ClinicalTrials.gov/show/NCT02754765 Recruiting Médecins Sans Frontières, France 2020-09-30
NCT02753387 Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Cancer https://ClinicalTrials.gov/show/NCT02753387 Completed Rennes University Hospital 2018-09-05
NCT02750761 A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013) https://ClinicalTrials.gov/show/NCT02750761 Completed Merck Sharp & Dohme Corp. 2018-12-16
NCT02729038 Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function https://ClinicalTrials.gov/show/NCT02729038 Completed GlaxoSmithKline 2017-06-20
NCT02690181 Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects. https://ClinicalTrials.gov/show/NCT02690181 Completed GlaxoSmithKline 2016-11-02
NCT02687906 Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections https://ClinicalTrials.gov/show/NCT02687906 Recruiting Melinta Therapeutics, Inc. 2021-08-31
NCT02655302 Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD https://ClinicalTrials.gov/show/NCT02655302 Recruiting University Hospital, Lille 2025-07-31
NCT02598141 Grinding Versus Standard Methods for the Treatment of Per-operative Bacteriological Samples Associated With Osteo-articular Sepsis https://ClinicalTrials.gov/show/NCT02598141 Recruiting Centre Hospitalier Universitaire de Nīmes 2018-11-30
NCT02436876 Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites https://ClinicalTrials.gov/show/NCT02436876 Completed Microbion Corporation 2018-07-26
NCT03978091 A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam https://ClinicalTrials.gov/show/NCT03978091 Recruiting National Institute of Allergy and Infectious Diseases (NIAID) 2020-11-04
NCT03568942 Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis) https://ClinicalTrials.gov/show/NCT03568942 Completed GlaxoSmithKline 2019-01-07
NCT03397433 ANti-infective Stewardship Using the Wisca Tool in the Electronic Medical Record https://ClinicalTrials.gov/show/NCT03397433 Completed NorthShore University HealthSystem 2018-07-31
NCT02553083 High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection https://ClinicalTrials.gov/show/NCT02553083 Recruiting Rabin Medical Center 2020-09-30
NCT02543827 Evaluation of the Efficacy and Safety of MV140 https://ClinicalTrials.gov/show/NCT02543827 Active, not recruiting Inmunotek S.L. 2020-12-31
NCT02541695 Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli https://ClinicalTrials.gov/show/NCT02541695 Completed NIZO Food Research 2016-03-31
NCT02527681 Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics https://ClinicalTrials.gov/show/NCT02527681 Recruiting Basilea Pharmaceutica 2020-12-31
NCT02500654 Regenerative Surgical Treatment of Peri-implantitis https://ClinicalTrials.gov/show/NCT02500654 Completed Region Gävleborg 2014-01-31
NCT02475876 PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children https://ClinicalTrials.gov/show/NCT02475876 Active, not recruiting Duke University 2018-08-31
NCT02452047 Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013) https://ClinicalTrials.gov/show/NCT02452047 Completed Merck Sharp & Dohme Corp. 2017-09-18
NCT02378480 Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23) https://ClinicalTrials.gov/show/NCT02378480 Completed Paratek Pharmaceuticals Inc 2016-04-30
NCT02375477 Improved Adherence to C. Difficile Isolation Protocols Through Improved Education Methods https://ClinicalTrials.gov/show/NCT02375477 Completed Case Comprehensive Cancer Center 2016-01-06
NCT02361866 To Evaluate the Effectiveness(Immunogeneicity) and Safety of ‘GC1107’ Administered Intramuscularly in Healthy Adults https://ClinicalTrials.gov/show/NCT02361866 Completed Green Cross Corporation 2014-09-30
NCT02339155 Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed https://ClinicalTrials.gov/show/NCT02339155 Completed Emergent BioSolutions 2017-01-03
NCT02306330 MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial https://ClinicalTrials.gov/show/NCT02306330 Completed Oxford University Clinical Research Unit, Vietnam 2016-01-31
NCT02294175 Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm https://ClinicalTrials.gov/show/NCT02294175 Completed North Florida Foundation for Research and Education 2017-12-31
NCT02292498 Thermal Imaging to Diagnose and Monitor Suspected Bacterial Infections https://ClinicalTrials.gov/show/NCT02292498 Completed Massachusetts General Hospital 2016-06-30
NCT02285075 Temocillin Pharmacokinetic in Hemodialysis https://ClinicalTrials.gov/show/NCT02285075 Completed AZ Sint-Jan AV 2014-12-31
NCT02269319 MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection https://ClinicalTrials.gov/show/NCT02269319 Completed MicuRx 2015-08-31
NCT02268279 Pharmacokinetics and Safety of Solithromycin in Adolescents and Children https://ClinicalTrials.gov/show/NCT02268279 Completed Melinta Therapeutics, Inc. 2016-10-31
NCT02266706 Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010) https://ClinicalTrials.gov/show/NCT02266706 Completed Cubist Pharmaceuticals LLC 2017-06-08
NCT02214433 A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers https://ClinicalTrials.gov/show/NCT02214433 Completed Debiopharm International SA 2015-02-28
NCT02162199 A Single Dose Study of Debio 1450 in Healthy Subjects https://ClinicalTrials.gov/show/NCT02162199 Completed Debiopharm International SA 2014-10-31
NCT02146209 Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate. https://ClinicalTrials.gov/show/NCT02146209 Completed Verisfield UK Ltd. Greek Branch 2014-06-30
NCT02134834 A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595 https://ClinicalTrials.gov/show/NCT02134834 Completed Meiji Seika Pharma Co., Ltd. 2014-08-31
NCT02134301 Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections https://ClinicalTrials.gov/show/NCT02134301 Recruiting Melinta Therapeutics, Inc. 2021-03-31
NCT02092506 RCT: Triple vs Sequential vs Concomitant Therapy H Pylori https://ClinicalTrials.gov/show/NCT02092506 Completed Changi General Hospital 2014-06-30
NCT02079298 Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants https://ClinicalTrials.gov/show/NCT02079298 Completed Karolinska Institutet 2015-09-30
NCT02066402 Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) https://ClinicalTrials.gov/show/NCT02066402 Completed Bayer 2016-03-06
NCT01283581 A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections https://ClinicalTrials.gov/show/NCT01283581 Completed Melinta Therapeutics, Inc. 2011-11-30
NCT01271998 Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg https://ClinicalTrials.gov/show/NCT01271998 Completed Trius Therapeutics LLC 2011-01-03
NCT02052388 Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections https://ClinicalTrials.gov/show/NCT02052388 Completed Innovation Pharmaceuticals, Inc. 2014-10-31
NCT02045849 Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects https://ClinicalTrials.gov/show/NCT02045849 Completed GlaxoSmithKline 2014-08-21
NCT02045797 Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections https://ClinicalTrials.gov/show/NCT02045797 Completed GlaxoSmithKline 2015-06-29
NCT02013141 Telavancin Pediatric PK Study (Ages >3 Months to 17 Years) https://ClinicalTrials.gov/show/NCT02013141 Recruiting Cumberland Pharmaceuticals 2022-12-31
NCT01984684 Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections https://ClinicalTrials.gov/show/NCT01984684 Completed Melinta Therapeutics, Inc. 2015-12-31
NCT01968395 Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure https://ClinicalTrials.gov/show/NCT01968395 Completed Erasme University Hospital 2014-08-31
NCT01966055 Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents https://ClinicalTrials.gov/show/NCT01966055 Completed Melinta Therapeutics, Inc. 2014-08-31
NCT01949103 TD-1607 MAD Study in Healthy Subjects https://ClinicalTrials.gov/show/NCT01949103 Completed Theravance Biopharma 2014-06-30
NCT01946568 A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years. https://ClinicalTrials.gov/show/NCT01946568 Completed Durata Therapeutics Inc., an affiliate of Allergan plc 2015-04-30
NCT01934205 To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944 https://ClinicalTrials.gov/show/NCT01934205 Completed GlaxoSmithKline 2013-12-21
NCT01897779 Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT01897779 Completed Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) 2014-02-28
NCT01892358 Preventing Bacterial and Viral Infections Among Injection Drug Users https://ClinicalTrials.gov/show/NCT01892358 Completed Butler Hospital 2019-08-31
NCT01845246 Multicentric Study About the Usefulness of Monitoring Plasma Levels of Colistin and Sodium Colistimethate in Patients With Infections Due to Multi-drug Resistant Gram Negative Bacilli, Treated With Colistin https://ClinicalTrials.gov/show/NCT01845246 Completed Parc de Salut Mar 2015-01-31
NCT01839188 Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) https://ClinicalTrials.gov/show/NCT01839188 Completed MCM Vaccines B.V. 2014-03-19
NCT01839175 Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination https://ClinicalTrials.gov/show/NCT01839175 Completed Sanofi 2014-07-31
NCT01817075 Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01817075 Completed Children’s Oncology Group 2019-03-31
NCT01812382 Retapamulin Microdialysis Feasibility Study https://ClinicalTrials.gov/show/NCT01812382 Completed GlaxoSmithKline 2014-05-27
NCT01811732 Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections https://ClinicalTrials.gov/show/NCT01811732 Completed Melinta Therapeutics, Inc. 2014-07-31
NCT01800942 Prevention of Bacterial Infections in Newborn https://ClinicalTrials.gov/show/NCT01800942 Completed London School of Hygiene and Tropical Medicine 2014-12-31
NCT01800396 Milk Ingredients and Resistance Against E-coli-induced GastroEnteritis (MIRAGE) https://ClinicalTrials.gov/show/NCT01800396 Completed NIZO Food Research 2013-05-31
NCT01772836 Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination https://ClinicalTrials.gov/show/NCT01772836 Completed Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) 2013-03-31
NCT01751269 Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT01751269 Completed Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) 2013-07-31
NCT01746654 Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients https://ClinicalTrials.gov/show/NCT01746654 Completed GangaGen, Inc. 2015-10-31
NCT01744730 Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile https://ClinicalTrials.gov/show/NCT01744730 Completed Duke University 2014-08-31
NCT01732250 Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem https://ClinicalTrials.gov/show/NCT01732250 Completed Rabin Medical Center 2017-01-31
NCT01709266 The Effect of Probiotics on E. Coli-induced Gastroenteritis https://ClinicalTrials.gov/show/NCT01709266 Completed NIZO Food Research 2012-11-30
NCT01702649 Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT01702649 Completed Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) 2012-11-30
NCT01689207 To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) https://ClinicalTrials.gov/show/NCT01689207 Completed Pfizer 2014-12-31
NCT01663389 A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose https://ClinicalTrials.gov/show/NCT01663389 Completed GlaxoSmithKline 2012-10-05
NCT01648179 A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects https://ClinicalTrials.gov/show/NCT01648179 Completed GlaxoSmithKline 2012-05-31
NCT01638702 Study of Complication Rates Associated With PICC for Left vs Right https://ClinicalTrials.gov/show/NCT01638702 Completed McGill University Health Centre/Research Institute of the McGill University Health Centre 2015-09-30
NCT01623154 POCone-UBiT-IR300 Pediatric Comparison Study https://ClinicalTrials.gov/show/NCT01623154 Completed Otsuka America Pharmaceutical 2013-03-31
NCT01610388 A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects https://ClinicalTrials.gov/show/NCT01610388 Completed GlaxoSmithKline 2012-01-26
NCT01608815 Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects https://ClinicalTrials.gov/show/NCT01608815 Completed Sanofi 2012-09-30
NCT01587937 Hospital Wide Roll-Out of Antimicrobial Stewardship https://ClinicalTrials.gov/show/NCT01587937 Completed Sunnybrook Health Sciences Centre 2012-04-30
NCT01586169 Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination https://ClinicalTrials.gov/show/NCT01586169 Completed Centre d’Appui à la lutte contre la Maladie 2010-02-28
NCT01553279 Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) https://ClinicalTrials.gov/show/NCT01553279 Completed MCM Vaccines B.V. 2013-09-27
NCT01528969 Effect of Xylitol on Oral Microbiota in Children https://ClinicalTrials.gov/show/NCT01528969 Completed Kuwait University 2012-04-30
NCT01519492 A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci https://ClinicalTrials.gov/show/NCT01519492 Completed Affinium Pharmaceuticals, Ltd 2012-08-31
NCT01506986 Helicobacter Eradication Aspirin Trial https://ClinicalTrials.gov/show/NCT01506986 Active, not recruiting University of Nottingham 2017-10-31
NCT01485705 Retrospective Examination of Initial Care of Severe Bacterial Infections of the Child https://ClinicalTrials.gov/show/NCT01485705 Completed Nantes University Hospital 2014-01-31
NCT01480258 Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) https://ClinicalTrials.gov/show/NCT01480258 Completed MCM Vaccines B.V. 2013-10-09
NCT01446289 Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings https://ClinicalTrials.gov/show/NCT01446289 Completed Novartis 2013-04-30
NCT01431989 Amoxicillin Bioequivalence Study Brazil - Fast https://ClinicalTrials.gov/show/NCT01431989 Completed GlaxoSmithKline 2011-06-11
NCT01421511 TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections https://ClinicalTrials.gov/show/NCT01421511 Completed Trius Therapeutics LLC 2013-01-10
NCT01412801 Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings https://ClinicalTrials.gov/show/NCT01412801 Completed Novartis 2012-10-31
NCT01402713 To Evaluate the Effectiveness(Immunogenicity) and Safety of ‘GC1107’ Administered Intramuscularly in Healthy Children https://ClinicalTrials.gov/show/NCT01402713 Completed Green Cross Corporation 2013-11-30
NCT01381848 A Study of Doripenem in Infants Less Than 12 Weeks of Age https://ClinicalTrials.gov/show/NCT01381848 Completed Janssen Research & Development, LLC 2012-04-30
NCT01371656 Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT01371656 Completed Children’s Oncology Group 2017-06-30
NCT01341639 Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) https://ClinicalTrials.gov/show/NCT01341639 Completed MCM Vaccines B.V. 2013-03-13
NCT01340937 A Study of V419 Given Concomitantly With Prevnar 13â„¢ and RotaTeqâ„¢ (V419-006) https://ClinicalTrials.gov/show/NCT01340937 Completed Merck Sharp & Dohme Corp. 2012-12-18
NCT01337167 Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13â„¢ and RotaTeqâ„¢ (V419-005) https://ClinicalTrials.gov/show/NCT01337167 Completed Merck Sharp & Dohme Corp. 2013-05-09
NCT00353158 A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity https://ClinicalTrials.gov/show/NCT00353158 Completed National Institutes of Health Clinical Center (CC) 2011-09-20
NCT04404855 Antibiotic Selection Using Next Generation Sequencing vs Urine Culture https://ClinicalTrials.gov/show/NCT04404855 Recruiting The University of Texas Health Science Center at San Antonio 2022-12-31
NCT04297176 Economic Evaluation of Vancomycin Therapeutic Drug Monitoring Methods https://ClinicalTrials.gov/show/NCT04297176 Active, not recruiting Hamad Medical Corporation 2020-07-30
NCT04291768 Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia https://ClinicalTrials.gov/show/NCT04291768 Recruiting Hvidovre University Hospital 2023-10-01
NCT04263792 [18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects https://ClinicalTrials.gov/show/NCT04263792 Recruiting University of Pennsylvania 2021-01-31
NCT04215991 Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients https://ClinicalTrials.gov/show/NCT04215991 Recruiting Shionogi Inc. 2023-03-15
NCT04100772 Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above https://ClinicalTrials.gov/show/NCT04100772 Recruiting CanSino Biologics Inc. 2020-10-01
NCT04079790 Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects https://ClinicalTrials.gov/show/NCT04079790 Completed GlaxoSmithKline 2019-11-25
NCT04070469 Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment (MAX-AMOX) https://ClinicalTrials.gov/show/NCT04070469 Recruiting University Hospital, Clermont-Ferrand 2021-12-31
NCT04067531 Treatment of BV With First Deqularum and Then Direkt After Clindamycin https://ClinicalTrials.gov/show/NCT04067531 Recruiting Skaraborg Hospital 2020-08-01
NCT04020341 A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI) https://ClinicalTrials.gov/show/NCT04020341 Recruiting GlaxoSmithKline 2021-04-28
NCT04011657 Effective Antimicrobial StewaRdship StrategIES (ARIES) https://ClinicalTrials.gov/show/NCT04011657 Completed Tan Tock Seng Hospital 2017-09-30
NCT04005560 Patient’s Quality of Life Assessment 5 to 10 Years After Hospitalization in Intensive Care Unit for a Severe Bacterial Infection https://ClinicalTrials.gov/show/NCT04005560 Recruiting Nantes University Hospital 2020-07-26
NCT03998865 Bacterial Microbiota Characterization on Implant-supported PEEK and Titanium Provisional Abutments https://ClinicalTrials.gov/show/NCT03998865 Completed University of Concepcion, Chile 2019-12-11
NCT03969901 Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021) https://ClinicalTrials.gov/show/NCT03969901 Recruiting Merck Sharp & Dohme Corp. 2022-11-13
NCT03964493 TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection https://ClinicalTrials.gov/show/NCT03964493 Recruiting TenNor Therapeutics Limited 2019-09-18
NCT03941951 Study to Optimize the Use of New Antibiotics https://ClinicalTrials.gov/show/NCT03941951 Recruiting Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 2020-12-31
NCT03939429 Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT03939429 Completed Qpex Biopharma, Inc. 2019-10-06
NCT03903783 Impact of Cefotaxime and Ceftriaxone on the Emergence and Carrying of Multidrug-Resistant Bacteria https://ClinicalTrials.gov/show/NCT03903783 Active, not recruiting Groupe Hospitalier Paris Saint Joseph 2020-01-06
NCT03816956 Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301 https://ClinicalTrials.gov/show/NCT03816956 Recruiting Aridis Pharmaceuticals, Inc. 2020-08-31
NCT03774940 Blood Parameters as a Predictor of Fever After Percutaneous Nephrolithotomy https://ClinicalTrials.gov/show/NCT03774940 Completed TC Erciyes University 2013-12-01
NCT03761043 Nurse Promotion of IV to PO Antimicrobial Conversion https://ClinicalTrials.gov/show/NCT03761043 Completed Kelowna General Hospital 2019-04-07
NCT03752424 Topical Silver Nanoparticles for Microbial Activity https://ClinicalTrials.gov/show/NCT03752424 Recruiting Al-Azhar University 2020-01-12
NCT03747497 Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection https://ClinicalTrials.gov/show/NCT03747497 Recruiting MicuRx 2019-05-30
NCT03696550 A Safety and PK Study of IV Eravacycline https://ClinicalTrials.gov/show/NCT03696550 Recruiting Tetraphase Pharmaceuticals, Inc. 2020-08-27
NCT03688321 Probiotic on Prevention of GBS Vaginal Infection During Pregnancy https://ClinicalTrials.gov/show/NCT03688321 Recruiting China Medical University Hospital 2019-07-31
NCT03671967 PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) https://ClinicalTrials.gov/show/NCT03671967 Recruiting Rambam Health Care Campus 2024-01-31
NCT03667937 Effectiveness of a Hydrophobic Dressing for Microorganisms’ Colonization and Infection Control of Vascular Ulcers https://ClinicalTrials.gov/show/NCT03667937 Recruiting University of Malaga 2020-12-30
NCT03633188 Stool Biobanking and Impact of Antimicrobials on the Gut Microbiota in Patients With Bone and Joint Infection https://ClinicalTrials.gov/show/NCT03633188 Recruiting Hospices Civils de Lyon 2022-07-31
NCT03590600 A Single Ascending Dose Study of BTZ043 https://ClinicalTrials.gov/show/NCT03590600 Completed Ludwig-Maximilians - University of Munich 2018-08-14
NCT03562117 Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function https://ClinicalTrials.gov/show/NCT03562117 Completed GlaxoSmithKline 2018-12-26
NCT03450187 A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study https://ClinicalTrials.gov/show/NCT03450187 Completed Tetraphase Pharmaceuticals, Inc. 2018-12-31
NCT03440216 Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units https://ClinicalTrials.gov/show/NCT03440216 Recruiting Université Catholique de Louvain 2019-10-15
NCT03424525 11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects https://ClinicalTrials.gov/show/NCT03424525 Recruiting University of Pennsylvania 2020-11-30
NCT01262885 A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT01262885 Completed GlaxoSmithKline 2011-08-25
NCT01244698 Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction https://ClinicalTrials.gov/show/NCT01244698 Completed Stony Brook University 2014-05-31
NCT01225042 The Effect of Probiotics on E. Coli Gastroenteritis https://ClinicalTrials.gov/show/NCT01225042 Completed NIZO Food Research 2010-12-31
NCT01209078 GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection https://ClinicalTrials.gov/show/NCT01209078 Completed GlaxoSmithKline 2011-01-18
NCT01170221 TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections. https://ClinicalTrials.gov/show/NCT01170221 Completed Trius Therapeutics LLC 2011-09-30
NCT01156077 Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients https://ClinicalTrials.gov/show/NCT01156077 Completed Trius Therapeutics LLC 2011-09-24
NCT01119105 Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) https://ClinicalTrials.gov/show/NCT01119105 Completed Nabriva Therapeutics AG 2010-12-31
NCT01111864 Changes in Microbiota and Iron Status After Iron Fortification of Complementary Foods https://ClinicalTrials.gov/show/NCT01111864 Completed Swiss Federal Institute of Technology 2012-09-30
NCT01074775 Human Innate Immune Responses To Mycobacterial Aerodigestive Tract Infection https://ClinicalTrials.gov/show/NCT01074775 Completed St George’s, University of London 2007-09-30
NCT01059890 Cerebral Antibiotics Distribution After Acute Brain Injury https://ClinicalTrials.gov/show/NCT01059890 Completed Poitiers University Hospital 2013-06-30
NCT01058824 Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule https://ClinicalTrials.gov/show/NCT01058824 Completed Pfizer 2009-04-30
NCT01019395 Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics https://ClinicalTrials.gov/show/NCT01019395 Completed Cubist Pharmaceuticals LLC 2012-03-20
NCT01018641 An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults https://ClinicalTrials.gov/show/NCT01018641 Completed Pfizer 2011-01-31
NCT01015014 Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections https://ClinicalTrials.gov/show/NCT01015014 Completed Pfizer 2010-05-13
NCT01012089 Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease https://ClinicalTrials.gov/show/NCT01012089 Completed University of Oklahoma 2014-04-30
NCT00983255 Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA) https://ClinicalTrials.gov/show/NCT00983255 Completed Trius Therapeutics LLC 2010-01-31
NCT00965848 A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections https://ClinicalTrials.gov/show/NCT00965848 Completed Janssen-Cilag Ltd.,Thailand 2010-07-31
NCT00945152 Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM) https://ClinicalTrials.gov/show/NCT00945152 Recruiting Robert S Berman MD 2020-12-31
NCT00939562 Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate https://ClinicalTrials.gov/show/NCT00939562 Completed Pfizer 2008-12-31
NCT00924911 Relative Bioavailability Study in Healthy Subjects https://ClinicalTrials.gov/show/NCT00924911 Completed GlaxoSmithKline 2009-07-09
NCT00896558 A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects https://ClinicalTrials.gov/show/NCT00896558 Completed GlaxoSmithKline 2009-09-25
NCT00852540 Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA https://ClinicalTrials.gov/show/NCT00852540 Completed GlaxoSmithKline 2010-07-31
NCT04328051 Influence of the Implant-prosthetic Connection in the Marginal Bone Loss and Bacterial Leakage https://ClinicalTrials.gov/show/NCT04328051 Recruiting University of Barcelona 2021-06-13
NCT01252199 Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2 https://ClinicalTrials.gov/show/NCT01252199 Completed Thallion Pharmaceuticals 2012-12-31
NCT00828867 Single Dose Escalation First Time in Human PK Study https://ClinicalTrials.gov/show/NCT00828867 Completed GlaxoSmithKline 2009-12-07
NCT03397914 Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections https://ClinicalTrials.gov/show/NCT03397914 Recruiting National Cancer Institute, Egypt 2019-05-31
NCT04126031 Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants. https://ClinicalTrials.gov/show/NCT04126031 Recruiting Pfizer 2021-12-18
NCT03925480 Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial https://ClinicalTrials.gov/show/NCT03925480 Recruiting Murdoch Childrens Research Institute 2021-08-31
NCT03332732 VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT03332732 Completed VenatoRx Pharmaceuticals, Inc. 2017-12-20
NCT02426918 Study of Debio 1450 for Bacterial Skin Infections https://ClinicalTrials.gov/show/NCT02426918 Completed Debiopharm International SA 2016-08-31
NCT02572791 Staph Household Intervention for Eradication (SHINE) https://ClinicalTrials.gov/show/NCT02572791 Recruiting Washington University School of Medicine 2021-08-31
NCT03801213 Evaluation of Urine Samples Obtained by Bladder Stimulation for the Diagnosis of Urinary Tract Infection in Infants https://ClinicalTrials.gov/show/NCT03801213 Recruiting Fondation Lenval 2020-12-31
NCT00760279 An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates https://ClinicalTrials.gov/show/NCT00760279 Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NA
NCT00723502 Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients https://ClinicalTrials.gov/show/NCT00723502 Completed MerLion Pharmaceuticals GmbH 2009-04-30
NCT00692848 Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source https://ClinicalTrials.gov/show/NCT00692848 Completed St. Justine’s Hospital 2007-11-30
NCT00684177 Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL) https://ClinicalTrials.gov/show/NCT00684177 Completed GlaxoSmithKline 2009-10-31
NCT00678106 Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections https://ClinicalTrials.gov/show/NCT00678106 Completed Pfizer 2009-07-31
NCT00670215 BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis https://ClinicalTrials.gov/show/NCT00670215 Completed Bayer NA
NCT00668044 Ciprofloxacin on Burned Patients https://ClinicalTrials.gov/show/NCT00668044 Completed Bayer 2003-11-30
NCT00633152 Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections https://ClinicalTrials.gov/show/NCT00633152 Completed Forest Laboratories 2008-07-31
NCT00629382 Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis https://ClinicalTrials.gov/show/NCT00629382 Completed St. Bortolo Hospital 2008-04-30
NCT00575380 Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery https://ClinicalTrials.gov/show/NCT00575380 Completed Merck Sharp & Dohme Corp. 2008-06-30
NCT00575367 Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers https://ClinicalTrials.gov/show/NCT00575367 Completed Merck Sharp & Dohme Corp. 2008-10-31
NCT00564447 Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers https://ClinicalTrials.gov/show/NCT00564447 Completed Merck Sharp & Dohme Corp. 2007-12-31
NCT00555061 Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. https://ClinicalTrials.gov/show/NCT00555061 Completed GlaxoSmithKline 2008-08-31
NCT00551915 A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003) https://ClinicalTrials.gov/show/NCT00551915 Completed Merck Sharp & Dohme Corp. 2003-01-31
NCT00551629 A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002) https://ClinicalTrials.gov/show/NCT00551629 Completed Merck Sharp & Dohme Corp. 2003-03-31
NCT00539994 Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus https://ClinicalTrials.gov/show/NCT00539994 Completed GlaxoSmithKline 2008-01-31
NCT00517673 To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects https://ClinicalTrials.gov/show/NCT00517673 Completed GlaxoSmithKline 2008-09-30
NCT00515151 Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride https://ClinicalTrials.gov/show/NCT00515151 Completed University Hospital Freiburg NA
NCT00515034 A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia https://ClinicalTrials.gov/show/NCT00515034 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2008-11-30
NCT00509938 Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients https://ClinicalTrials.gov/show/NCT00509938 Completed AM-Pharma 2006-11-30
NCT00501150 Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections https://ClinicalTrials.gov/show/NCT00501150 Completed Imperial College London NA
NCT00493922 Trial of Rapid Diagnostic Tests in Rural Ghana https://ClinicalTrials.gov/show/NCT00493922 Completed London School of Hygiene and Tropical Medicine 2008-12-31
NCT00490477 The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT00490477 Completed University of Turin, Italy 2007-07-31
NCT00488345 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age https://ClinicalTrials.gov/show/NCT00488345 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2009-09-30
NCT00488189 Study Evaluation Tazocin Intervention https://ClinicalTrials.gov/show/NCT00488189 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2008-02-29
NCT00478855 Tazocin Intervention Study https://ClinicalTrials.gov/show/NCT00478855 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00472667 PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA) https://ClinicalTrials.gov/show/NCT00472667 Completed Assistance Publique - Hôpitaux de Paris 2008-05-31
NCT00431483 Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards https://ClinicalTrials.gov/show/NCT00431483 Completed Ludwig-Maximilians - University of Munich 2008-02-29
NCT00427141 A Three-Part Study Of GSK580416 In Healthy Subjects https://ClinicalTrials.gov/show/NCT00427141 Completed GlaxoSmithKline NA
NCT00424190 Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections https://ClinicalTrials.gov/show/NCT00424190 Completed Forest Laboratories 2007-11-30
NCT00423657 Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections https://ClinicalTrials.gov/show/NCT00423657 Completed Forest Laboratories 2007-12-31
NCT00410527 Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients https://ClinicalTrials.gov/show/NCT00410527 Completed National Institutes of Health Clinical Center (CC) NA
NCT00406198 Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis https://ClinicalTrials.gov/show/NCT00406198 Completed Hopital Lariboisière NA
NCT00389558 Antiseptic Use and Dressing Application https://ClinicalTrials.gov/show/NCT00389558 Completed Maternite Regionale Universitaire 2008-09-30
NCT00366249 Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis. https://ClinicalTrials.gov/show/NCT00366249 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2009-03-31
NCT00358371 Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg) https://ClinicalTrials.gov/show/NCT00358371 Completed GlaxoSmithKline 2005-02-08
NCT00357539 Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers https://ClinicalTrials.gov/show/NCT00357539 Completed Laboratoires Thea NA
NCT00357383 Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers https://ClinicalTrials.gov/show/NCT00357383 Completed Laboratoires Thea NA
NCT00357292 Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers https://ClinicalTrials.gov/show/NCT00357292 Completed Laboratoires Thea NA
NCT00356850 Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers https://ClinicalTrials.gov/show/NCT00356850 Completed Laboratoires Thea NA
NCT00356772 Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers https://ClinicalTrials.gov/show/NCT00356772 Completed Laboratoires Thea NA
NCT00347386 Therapeutic Zinc in Infant Bacterial Illness https://ClinicalTrials.gov/show/NCT00347386 Completed Centre For International Health 2008-12-31
NCT00324168 Steroids for Corneal Ulcers Trial https://ClinicalTrials.gov/show/NCT00324168 Completed University of California, San Francisco 2011-02-28
NCT00318344 Evaluation of Atuna Racemosa Toxicity https://ClinicalTrials.gov/show/NCT00318344 Completed Mayo Clinic 2007-11-30
NCT00288418 Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization https://ClinicalTrials.gov/show/NCT00288418 Completed Angiotech Pharmaceuticals 2007-07-31
NCT00271440 Effect of Chlorhexidine Cleansing on Skin Flora of Newborns in Nepal https://ClinicalTrials.gov/show/NCT00271440 Completed Johns Hopkins Bloomberg School of Public Health 2006-04-30
NCT00258102 A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections https://ClinicalTrials.gov/show/NCT00258102 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00254696 Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs) https://ClinicalTrials.gov/show/NCT00254696 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2005-03-31
NCT00229060 Doripenem in the Treatment of Complicated Intra-Abdominal Infections https://ClinicalTrials.gov/show/NCT00229060 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00216450 Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults. https://ClinicalTrials.gov/show/NCT00216450 Completed Janssen Cilag Pharmaceutica S.A.C.I., Greece NA
NCT00210938 Doripenem in the Treatment of Complicated Intra-Abdominal Infections https://ClinicalTrials.gov/show/NCT00210938 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00205816 Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens. https://ClinicalTrials.gov/show/NCT00205816 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2005-11-30
NCT00200928 Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood. https://ClinicalTrials.gov/show/NCT00200928 Completed The Netherlands Asthma Foundation NA
NCT00198627 Etiology, Prevention and Treatment of Neonatal Infections in the Community https://ClinicalTrials.gov/show/NCT00198627 Completed Johns Hopkins Bloomberg School of Public Health 2007-09-30
NCT00176124 Leukocyte Depletion of Autologous Whole Blood https://ClinicalTrials.gov/show/NCT00176124 Completed Heidelberg University 2005-04-30
NCT00170586 Novel Protective Underglove https://ClinicalTrials.gov/show/NCT00170586 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00170430 Reducing Vaginal Infections in Women https://ClinicalTrials.gov/show/NCT00170430 Completed University of Washington 2006-12-31
NCT00147511 Time To Efficacy and Onset Of Action Of Linezolid https://ClinicalTrials.gov/show/NCT00147511 Completed Pfizer NA
NCT00136292 Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics https://ClinicalTrials.gov/show/NCT00136292 Completed Cubist Pharmaceuticals LLC 2006-08-01
NCT00133874 Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo https://ClinicalTrials.gov/show/NCT00133874 Completed GlaxoSmithKline 2005-09-30
NCT00100386 Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial https://ClinicalTrials.gov/show/NCT00100386 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00100308 Unfractioned Heparin for Treatment of Sepsis https://ClinicalTrials.gov/show/NCT00100308 Completed Universidad de Antioquia 2007-07-31
NCT00081744 Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects https://ClinicalTrials.gov/show/NCT00081744 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2004-08-31
NCT00079989 Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms https://ClinicalTrials.gov/show/NCT00079989 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2005-11-30
NCT00079976 Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA) https://ClinicalTrials.gov/show/NCT00079976 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2005-06-30
NCT00062647 Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia https://ClinicalTrials.gov/show/NCT00062647 Completed Cumberland Pharmaceuticals 2006-08-31
NCT00044928 Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection https://ClinicalTrials.gov/show/NCT00044928 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2004-02-29
NCT00795145 A Study To Assess The Effect Of Linezolid On QTc Interval https://ClinicalTrials.gov/show/NCT00795145 Completed Pfizer 2009-03-31
NCT00037050 Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria https://ClinicalTrials.gov/show/NCT00037050 Completed Pfizer NA
NCT00035854 New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) https://ClinicalTrials.gov/show/NCT00035854 Completed Pfizer NA
NCT00008853 Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines https://ClinicalTrials.gov/show/NCT00008853 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00002344 A Study of Azithromycin in HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00002344 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002139 Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects. https://ClinicalTrials.gov/show/NCT00002139 Completed NIH AIDS Clinical Trials Information Service NA
NCT00000826 Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites https://ClinicalTrials.gov/show/NCT00000826 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000811 A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children https://ClinicalTrials.gov/show/NCT00000811 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00035269 New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia) https://ClinicalTrials.gov/show/NCT00035269 Completed Pfizer NA
NCT00004829 Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00004829 Completed FDA Office of Orphan Products Development NA
NCT00004747 Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis https://ClinicalTrials.gov/show/NCT00004747 Completed Office of Rare Diseases (ORD) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03290105 Microbial and Pharmacological Assessment of Chlorhexidine https://ClinicalTrials.gov/show/NCT03290105 Completed Hôpital Louis Mourier 2014-03-31
NCT03271580 Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing https://ClinicalTrials.gov/show/NCT03271580 Recruiting Indiana University 2021-02-28
NCT03252028 Rapid Test for Detection of the Focus of Infection in Post Neurosurgical Patients. https://ClinicalTrials.gov/show/NCT03252028 Recruiting University Hospital, Linkoeping 2019-12-01
NCT03243864 Study of Ceftazidime-Avibactam Blood Concentrations in Intensive Care Unit Patients With Renal Failure Requiring Continuous Dialysis https://ClinicalTrials.gov/show/NCT03243864 Recruiting Temple University 2020-03-21
NCT03192072 A Rapid Test for Acute Respiratory Illness https://ClinicalTrials.gov/show/NCT03192072 Completed Duke University 2019-09-06
NCT03172039 Antimicrobial Use and Stewardship in an Outpatient Hemodialysis Unit https://ClinicalTrials.gov/show/NCT03172039 Completed University Health Network, Toronto 2017-09-01
NCT03160040 A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting https://ClinicalTrials.gov/show/NCT03160040 Completed Melinta Therapeutics, Inc. 2018-05-01
NCT03159403 A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting https://ClinicalTrials.gov/show/NCT03159403 Completed Melinta Therapeutics, Inc. 2018-02-15
NCT03123705 El Paso Public Health Biorepository https://ClinicalTrials.gov/show/NCT03123705 Completed Texas Tech University Health Sciences Center, El Paso 2019-08-31
NCT03053258 Diagnostic Breath Analysis for Detection of Ventilator Acquired Pneumonia (VAP) https://ClinicalTrials.gov/show/NCT03053258 Completed Landon Pediatric Foundation 2018-10-31
NCT03016845 Pharmacokinetics of Ciprofloxacin in Critically Ill Patients https://ClinicalTrials.gov/show/NCT03016845 Completed Radboud University 2018-03-01
NCT02993575 Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients https://ClinicalTrials.gov/show/NCT02993575 Completed Radboud University 2018-03-01
NCT02979951 Fosfomycin i.v. for Treatment of Severely Infected Patients https://ClinicalTrials.gov/show/NCT02979951 Recruiting Infectopharm Arzneimittel GmbH 2020-06-30
NCT02962934 An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT https://ClinicalTrials.gov/show/NCT02962934 Completed Royal Brisbane and Women’s Hospital 2019-06-30
NCT02898948 Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department https://ClinicalTrials.gov/show/NCT02898948 Completed Centre Hospitalier Universitaire, Amiens 2016-10-18
NCT02852902 Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study. https://ClinicalTrials.gov/show/NCT02852902 Completed Spanish Network for Research in Infectious Diseases 2016-10-31
NCT02848534 The Value of the Neutrophil to Lymphocyte Ratio in the Diagnosis of Bacterial Infections https://ClinicalTrials.gov/show/NCT02848534 Completed Centre Hospitalier Universitaire, Amiens 2016-09-12
NCT02796716 Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections https://ClinicalTrials.gov/show/NCT02796716 Completed Denver Health and Hospital Authority 2016-12-31
NCT02794831 Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections https://ClinicalTrials.gov/show/NCT02794831 Completed Nantes University Hospital 2018-04-10
NCT02778672 Thermal Imaging of the Lung on a Smartphone to Differentiate Bacterial From Non Bacterial Causes of Pneumonia https://ClinicalTrials.gov/show/NCT02778672 Completed Boston University 2017-06-30
NCT02777632 Resistant Bacterial Infections in the Early Post LDLT Period https://ClinicalTrials.gov/show/NCT02777632 Completed Ain Shams University 2015-11-30
NCT02669823 Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region https://ClinicalTrials.gov/show/NCT02669823 Completed Sysmex Europe GmbH 2017-06-30
NCT04450680 Beta-lactam Therapeutic Drug Monitoring in Singapore https://ClinicalTrials.gov/show/NCT04450680 Recruiting Singapore General Hospital 2020-12-31
NCT02544230 Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia https://ClinicalTrials.gov/show/NCT02544230 Completed Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne 2011-12-31
NCT02533609 Elimination of Antibiotics During Citrate-anticoagulated Continuous-veno-venous-haemodialysis https://ClinicalTrials.gov/show/NCT02533609 Active, not recruiting Heinrich-Heine University, Duesseldorf 2020-08-31
NCT02311816 Increase in Procalcitonin Kinetics May be a Good Indicator of Starting Empirical Antibiotic Treatment in Critically Ill Patients https://ClinicalTrials.gov/show/NCT02311816 Completed Szeged University 2013-10-31
NCT02311452 Comparative Effectiveness of Intravenous v. Oral Antibiotic Therapy for Serious Bacterial Infections https://ClinicalTrials.gov/show/NCT02311452 Completed Children’s Hospital of Philadelphia 2012-12-31
NCT02294695 Early Procalcitonin Kinetics During Empirical Antibiotic Therapy in Critically Ill Patients https://ClinicalTrials.gov/show/NCT02294695 Completed Szeged University 2013-10-31
NCT02180906 Biomarkers in Patients With Flesh-eating Bacterial Infections https://ClinicalTrials.gov/show/NCT02180906 Completed Rigshospitalet, Denmark 2016-02-29
NCT02164409 Changes Associated With H. Pylori and Gastric Carcinogenesis https://ClinicalTrials.gov/show/NCT02164409 Recruiting Weill Medical College of Cornell University 2021-04-30
NCT02160860 Epidemiology of Helicobacter Pylori Infection Among Shanghai Children https://ClinicalTrials.gov/show/NCT02160860 Completed Children’s Hospital of Fudan University 2015-09-30
NCT02155114 Iron Homoeostasis in Inflammation https://ClinicalTrials.gov/show/NCT02155114 Completed University Hospital, Basel, Switzerland 2014-10-31
NCT02060513 Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections https://ClinicalTrials.gov/show/NCT02060513 Completed Denver Health and Hospital Authority 2016-11-30
NCT01289249 Meropenem Plasma Concentration Measurements at the Pediatric Medical Ward, Oslo University Hospital, Rikshospitalet https://ClinicalTrials.gov/show/NCT01289249 Completed Oslo University Hospital 2014-01-31
NCT02007343 Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch Hospitals https://ClinicalTrials.gov/show/NCT02007343 Completed UMC Utrecht 2016-03-31
NCT01932034 Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software https://ClinicalTrials.gov/show/NCT01932034 Completed Children’s Hospital Los Angeles 2016-07-01
NCT01904188 Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate? https://ClinicalTrials.gov/show/NCT01904188 Recruiting Michigan State University 2022-07-31
NCT01902589 Resistance of Helicobacter Pylori to Antibiotics in Children https://ClinicalTrials.gov/show/NCT01902589 Completed HaEmek Medical Center, Israel 2013-12-31
NCT01819298 Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy https://ClinicalTrials.gov/show/NCT01819298 Completed Far Eastern Memorial Hospital 2012-03-31
NCT01803100 Characterizing and Comparing the Profile of Microorganisms From Specific Body Sites and Environmental Surfaces in Newly Disinfected Patient Rooms https://ClinicalTrials.gov/show/NCT01803100 Completed Duke University 2015-07-31
NCT01788449 Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance https://ClinicalTrials.gov/show/NCT01788449 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2007-02-28
NCT01781182 Infant Antibiotic Resistance and Implications for Therapeutic Decision-making https://ClinicalTrials.gov/show/NCT01781182 Completed University Hospitals Cleveland Medical Center 2017-03-31
NCT01611740 Contribution of Real Time Analyses of CARdio-RESpiratory Signals to the Diagnosis of Infection in PREterM Infants https://ClinicalTrials.gov/show/NCT01611740 Completed Rennes University Hospital 2018-12-24
NCT01591486 Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding https://ClinicalTrials.gov/show/NCT01591486 Completed Chinese University of Hong Kong 2013-02-28
NCT01587768 WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics https://ClinicalTrials.gov/show/NCT01587768 Completed GlaxoSmithKline 2014-07-31
NCT01564758 Post Marketing Surveillance Study on Linezolid https://ClinicalTrials.gov/show/NCT01564758 Completed Pfizer 2005-03-31
NCT01445600 ALTARGO(Retapamulin) PMS(Post-marketing Surveillance) https://ClinicalTrials.gov/show/NCT01445600 Completed GlaxoSmithKline 2015-08-31
NCT03627000 Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a 2-stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection https://ClinicalTrials.gov/show/NCT03627000 Completed Hospices Civils de Lyon 2018-04-01
NCT04440631 Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection https://ClinicalTrials.gov/show/NCT04440631 Recruiting AO Research Institute Davos 2021-12-31
NCT04358991 Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDF https://ClinicalTrials.gov/show/NCT04358991 Completed University of Pittsburgh 2019-12-31
NCT04310722 Gram-negative Bacilli and MRSA Screening in ICU in China https://ClinicalTrials.gov/show/NCT04310722 Recruiting Sir Run Run Shaw Hospital 2020-10-31
NCT04287504 Point-of-care Tests for Bacterial Vaginosis and Candidosis https://ClinicalTrials.gov/show/NCT04287504 Recruiting Medical University of Vienna 2020-12-31
NCT04254991 A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-response Based Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Presenting to the ED With Suspicion of Acute Infection https://ClinicalTrials.gov/show/NCT04254991 Active, not recruiting MeMed Diagnostics Ltd. 2018-05-31
NCT04226001 Impact of a Carrier (Infection, Colonization) of Highly Bacteria Resistance on the Patient’s Quality of Life Hospital Environment https://ClinicalTrials.gov/show/NCT04226001 Recruiting Hospices Civils de Lyon 2021-02-28
NCT04178915 Study of Leukocyte Immunophenotype and the Lipid Transport System as Predictive Biomarkers of Severe Bacterial Infections https://ClinicalTrials.gov/show/NCT04178915 Enrolling by invitation The Republican Research and Practical Center for Epidemiology and Microbiology 2020-12-31
NCT04076345 Interest of the Presepsin Assay as a Biomarker of Bacterial Infection, in the Management of Newborns and Infants Under 3 Months of Age Admitted for Fever in Pediatric Emergency Service (Presepsin) https://ClinicalTrials.gov/show/NCT04076345 Recruiting University Hospital, Clermont-Ferrand 2020-08-31
NCT04067557 Diagnosis of Bacterial Vaginosis Comparing Modified Hay/Ison With Molecular Diagnosis https://ClinicalTrials.gov/show/NCT04067557 Completed Skaraborg Hospital 2013-05-01
NCT04055922 Comparison of Solid Organ Transplant https://ClinicalTrials.gov/show/NCT04055922 Enrolling by invitation Methodist Health System 2020-05-31
NCT03992703 Clinical Impact of Rapid AST Directly From Blood Cultures https://ClinicalTrials.gov/show/NCT03992703 Active, not recruiting Groupe Hospitalier Paris Saint Joseph 2019-10-30
NCT03985605 Therapeutic Drug Monitoring of Antiinfectives for Patients With Severe Illness = TAPSI https://ClinicalTrials.gov/show/NCT03985605 Recruiting Ludwig-Maximilians - University of Munich 2021-12-31
NCT03933748 Therapeutic Drug Monitoring of Teicoplanin in Children https://ClinicalTrials.gov/show/NCT03933748 Recruiting Shandong University 2025-11-30
NCT03925402 Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia https://ClinicalTrials.gov/show/NCT03925402 Recruiting Phramongkutklao College of Medicine and Hospital 2023-01-01
NCT03919032 Bacterial Infections in Patients With Cirrhosis in Argentina: Clinical and Microbiological Characteristics https://ClinicalTrials.gov/show/NCT03919032 Completed Hospital Italiano de Buenos Aires 2019-12-31
NCT03883230 Wound Infection Detection Evaluation, WIDE https://ClinicalTrials.gov/show/NCT03883230 Recruiting Cumbria Partnership NHS Foundation Trust 2019-12-31
NCT03858387 PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients https://ClinicalTrials.gov/show/NCT03858387 Recruiting Prince of Songkla University 2020-12-31
NCT03846921 Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections https://ClinicalTrials.gov/show/NCT03846921 Recruiting Hillel Yaffe Medical Center 2020-03-31
NCT03738683 Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients https://ClinicalTrials.gov/show/NCT03738683 Completed Radboud University 2019-09-01
NCT03721146 ENCAPSID Study : ENCApsulated Bacterial Infection and Primary, Secondary ImmunoDeficiency https://ClinicalTrials.gov/show/NCT03721146 Recruiting University Hospital, Caen 2021-09-01
NCT03696901 Xydalba Utilization Registry in Germany https://ClinicalTrials.gov/show/NCT03696901 Recruiting Correvio International Sarl 2020-06-30
NCT03655548 Optimization Management Study of Community Urinary Tract Infections Spectrum https://ClinicalTrials.gov/show/NCT03655548 Completed University Hospital, Brest 2017-02-28
NCT03646227 Multi-Drug Resistant Organism Network https://ClinicalTrials.gov/show/NCT03646227 Active, not recruiting Duke University 2020-06-30
NCT03625713 Bacterial Ano-rectitis Sexually Transmitted in a Specialized Consultation Center https://ClinicalTrials.gov/show/NCT03625713 Recruiting Groupe Hospitalier Paris Saint Joseph 2021-01-31
NCT03605498 OR PathTrac (Tracking Intra-operative Bacterial Transmission) https://ClinicalTrials.gov/show/NCT03605498 Completed University of Iowa 2018-02-12
NCT03599999 Study of Adverse Effects Occuring in Patients Receiving an Antibiotic Treatment With Temocillin https://ClinicalTrials.gov/show/NCT03599999 Completed Centre Hospitalier Universitaire, Amiens 2017-12-29
NCT03560440 Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients https://ClinicalTrials.gov/show/NCT03560440 Completed Universitaire Ziekenhuizen Leuven 2016-02-29
NCT03509727 Procalcitonin in Diagnosis of Bacterial Infections in Young Infants https://ClinicalTrials.gov/show/NCT03509727 Completed Belfast Health and Social Care Trust 2018-01-01
NCT03477760 Multi-Drug Resistant Bacteria Carriage After Travel https://ClinicalTrials.gov/show/NCT03477760 Completed Hopital Lariboisière 2016-12-31
NCT03475472 Direct Molecular Characterization of Bacteria From ICU and From the REHAB https://ClinicalTrials.gov/show/NCT03475472 Recruiting University Hospital, Basel, Switzerland 2020-06-30
NCT01173575 Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection https://ClinicalTrials.gov/show/NCT01173575 Completed Infectopharm Arzneimittel GmbH 2016-12-31
NCT01153880 United States Pharmacovigilence Retapamulin-Prescribing https://ClinicalTrials.gov/show/NCT01153880 Completed GlaxoSmithKline 2012-08-31
NCT00998309 Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan) https://ClinicalTrials.gov/show/NCT00998309 Completed Pfizer 2011-01-31
NCT00915213 Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy https://ClinicalTrials.gov/show/NCT00915213 Completed University of California, Irvine 2014-06-30
NCT00874367 Early-Onset Sepsis Surveillance Study https://ClinicalTrials.gov/show/NCT00874367 Completed NICHD Neonatal Research Network 2009-12-31
NCT03767374 Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs https://ClinicalTrials.gov/show/NCT03767374 Active, not recruiting Institut de Médecine et d’Epidémiologie Appliquée - Fondation Internationale Léon M’Ba 2019-06-30
NCT04282785 Point-of-care Monitoring of Antibiotic Concentration in Blood With UV-VIS Absorption Spectroscopy https://ClinicalTrials.gov/show/NCT04282785 Recruiting Uppsala University 2020-11-30
NCT00736554 What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center? https://ClinicalTrials.gov/show/NCT00736554 Completed Lawson Health Research Institute 2008-09-30
NCT00714402 Procalcitonin Level and Kinetics in Children With Bacterial Infections https://ClinicalTrials.gov/show/NCT00714402 Completed Shaare Zedek Medical Center NA
NCT00701948 New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the Newborn https://ClinicalTrials.gov/show/NCT00701948 Completed University Hospital, Strasbourg, France 2013-12-31
NCT00800488 Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months https://ClinicalTrials.gov/show/NCT00800488 Completed Assistance Publique - Hôpitaux de Paris 2011-02-28
NCT00449735 Quinolone Resistance in Bloodstream Isolates of Escherichia Coli https://ClinicalTrials.gov/show/NCT00449735 Completed University of Pittsburgh 2017-06-30
NCT00799591 French Study In ICU Patients Treated With Tigecycline https://ClinicalTrials.gov/show/NCT00799591 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2010-05-31
NCT00394784 Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream Isolates https://ClinicalTrials.gov/show/NCT00394784 Enrolling by invitation University of Pittsburgh 2025-12-31
NCT00275327 Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria https://ClinicalTrials.gov/show/NCT00275327 Completed University of Pittsburgh 2015-12-31
NCT00271531 Bacterial Pulmonary Infection in PICU https://ClinicalTrials.gov/show/NCT00271531 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2008-05-31
NCT00259909 Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT00259909 Completed GlaxoSmithKline 2006-11-07
NCT00210639 A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection https://ClinicalTrials.gov/show/NCT00210639 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2010-04-30
NCT00177957 Gram Negative Bacteremia, Risk Factors for Failure of Therapy https://ClinicalTrials.gov/show/NCT00177957 Completed University of Pittsburgh 2016-05-31
NCT00177814 Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit https://ClinicalTrials.gov/show/NCT00177814 Completed University of Pittsburgh 2017-06-30
NCT00167999 Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units https://ClinicalTrials.gov/show/NCT00167999 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00167960 Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit https://ClinicalTrials.gov/show/NCT00167960 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03367897 Bleeding Ulcer and Erosions Study “BLUE Study” https://ClinicalTrials.gov/show/NCT03367897 Completed Ostfold Hospital Trust 2017-12-31
NCT03225079 PERFORM = Pentaglobin® Registry For Outcome Report and Monitoring https://ClinicalTrials.gov/show/NCT03225079 Recruiting Jena University Hospital 2020-06-30
NCT02088840 Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Stem Cell Transplant https://ClinicalTrials.gov/show/NCT02088840 Completed Gruppo Italiano Trapianto di Midollo Osseo 2016-04-30
NCT04436991 Antibiotic Dosing in Geriatric Patients at the Emergency Department https://ClinicalTrials.gov/show/NCT04436991 Recruiting University Hospital, Ghent 2020-09-30
NCT03726216 Xydalba Utilization Registry in France https://ClinicalTrials.gov/show/NCT03726216 Recruiting Correvio International Sarl 2020-06-30
NCT02614144 Epidemiology of Hospital Acquired Pneumonia https://ClinicalTrials.gov/show/NCT02614144 Completed University Hospital Olomouc 2015-11-30